VOLORIDGE INVESTMENT MANAGEMENT, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$8,856,838
-3.1%
572,517
-1.6%
0.04%
+2.3%
Q2 2023$9,137,973
-45.5%
581,666
-42.8%
0.04%
-48.2%
Q1 2023$16,756,337
-4.8%
1,016,768
-9.9%
0.08%
-15.3%
Q4 2022$17,602,603
+42.1%
1,128,372
+18.2%
0.10%
+46.3%
Q3 2022$12,387,000
-13.9%
955,027
-6.8%
0.07%
-9.5%
Q2 2022$14,381,000
+216.3%
1,024,253
+222.5%
0.07%
+184.6%
Q1 2022$4,547,000
+112.2%
317,556
+101.9%
0.03%
+116.7%
Q4 2021$2,143,000
+59.8%
157,252
+114.1%
0.01%
+20.0%
Q1 2021$1,341,000
+39.4%
73,452
+39.0%
0.01%
+25.0%
Q4 2020$962,000
-57.4%
52,861
-58.2%
0.01%
-57.9%
Q3 2020$2,258,000
+66.3%
126,556
+67.1%
0.02%
+18.8%
Q2 2020$1,358,000
+15.3%
75,718
-2.4%
0.02%
-52.9%
Q1 2020$1,178,000
-83.8%
77,572
-78.9%
0.03%
-75.9%
Q4 2019$7,253,000
+128.9%
367,616
+99.6%
0.14%
+156.4%
Q3 2019$3,168,000
+722.9%
184,173
+747.0%
0.06%
+400.0%
Q2 2019$385,00021,7450.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders